Lennar (LEN) (HMA) (LH) (HSIC) (HSY) (IPXL) (LAZ) Price Targets Changed

Lennar Co. (NYSE: LEN), Health Management Associates (NYSE: HMA), Laboratory Corp. of America (NYSE: LH), Henry Schein, Inc. (NASDAQ: HSIC), Hershey (NYSE: HSY), Impax Laboratories, Inc. (NASDAQ: IPXL) and Lazard Ltd (NYSE: LAZ) had their price targets adjusted by analysts.

Lennar Co. (LEN) had its price target lowered by Guggenheim to $22.00. They have a “Buy” rating on the company.

Health Management Associates (HMA) had its price target lowered by Deutsche Bank (NYSE:DB) to $11.50.

Laboratory Corp. of America (LH) had its price target lowered by UBS AG (NYSE:UBS) to $92.00. They have a “Neutral” rating on the company.

Henry Schein, Inc. (HSIC) had its price target lowered by UBS AG from $76.00 to $70.00. They have a “Neutral” rating on the company.

Hershey (HSY) had its price target raised by Goldman Sachs (NYSE:GS) to $66.00. They have a “Neutral” rating on the company.

Impax Laboratories, Inc. (IPXL) had its price target lowered by UBS AG from $23.50 to $20.00. They have a “Neutral” rating on the company.

Lazard Ltd (LAZ) had its price target lowered by Credit Suisse (NYSE:CS) to $33.00. They have a “Neutral” rating on the company.